Mostrar el registro sencillo del ítem
dc.contributor.author | COVID-19 South Chile Group | |
dc.date.accessioned | 2024-09-26T00:26:08Z | |
dc.date.available | 2024-09-26T00:26:08Z | |
dc.date.issued | 2022-02-07 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | https://repositorio.uss.cl/handle/uss/12129 | |
dc.description | Funding Information: This work was supported by National Agency of Research and Development (ANID) projects COVID0422 (to MB), FONDEF ID20I10192 and ID18I10261 (to MB). FONDECYT 1190156 (to RS-R), 1180798 (to FV-E) and 3200913 (to FF-V). Proyecto FIC20-10 Gobierno Regional de Los Rıós (to VT). We also thank FONDEQUIP EQM150061. Reagents in the Krammer laboratory were generated with support of the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051, NIAID Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C), generous support of the JPB Foundation and the Open Philanthropy Project (research grant 2020-215611) (5384); and by anonymous donors. Funding Information: We especially thank all blood donors who participate in this study. COVID-19 South Chile Group: Gerardo Sol?s, Marcelo Pozas, Equipo de enfermer?a Servicio de Medicina Interna Hospital Base Osorno, Mar?a Paz Contreras, Equipo de enfermer?a de la Universidad de Los Lagos Osorno, Catherine Fern?ndez, Camila Rojas, Paulina Lagos, Roc?o Mej?as, Melissa Canales, Patricio Suazo, Pamela ?ngel, Romina Inostroza, Pamela Silva, Felipe Collao, Vanina Cuevas, Rodrigo O?ate, Daniel Salamanca, Javier Briones, Vanessa Villagr?n, Diana Bocaz, Andr?s Umanzor. Funding Information: Conflict of Interest: Authors JLG and RA were employed by company Ichor Biologics LLC. JLG and RA were partially supported by Ichor Biologics LLC. Publisher Copyright: Copyright © 2022 Fuentes-Villalobos, Garrido, Medina, Zambrano, Ross, Bravo, Gaete-Argel, Oyarzún-Arrau, Amanat, Soto-Rifo, Valiente-Echeverría, Ocampo, Esveile, Ferreira, Cabrera, Torres, Rioseco, Riquelme, Barría, Alvarez, Pinos, Krammer, Calvo, Barria and COVID-19 South Chile Group. | |
dc.description.abstract | The coronavirus disease 2019 (COVID19) pandemic has left researchers scrambling to identify the humoral immune correlates of protection from COVID-19. To date, the antibody mediated correlates of virus neutralization have been extensively studied. However, the extent that non-neutralizing functions contribute to anti-viral responses are ill defined. In this study, we profiled the anti-spike antibody subtype/subclass responses, along with neutralization and antibody-dependent natural killer cell functions in 83 blood samples collected between 4 and 201 days post-symptoms onset from a cohort of COVID-19 outpatients. We observed heterogeneous humoral responses against the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. Overall, anti-spike profiles were characterized by a rapid rise of IgA and sustained IgG titers. In addition, strong antibody-mediated natural killer effector responses correlated with milder disease and being female. While higher neutralization profiles were observed in males along with increased severity. These results give an insight into the underlying function of antibodies beyond neutralization and suggest that antibody-mediated natural killer cell activity is a key function of the humoral response against the SARS-CoV-2 spike protein. | en |
dc.language.iso | eng | |
dc.relation.ispartof | vol. 13 Issue: Pages: | |
dc.source | Frontiers in Immunology | |
dc.title | Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence | en |
dc.type | Artículo | |
dc.identifier.doi | 10.3389/fimmu.2022.796481 | |
dc.publisher.department | Facultad de Medicina y Ciencia |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |